PMID | Data | Article Title | Organization |
---|---|---|---|
26653735 | 81 | Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis. | Pfizer |
22175825 | 19 | Potent inhibitors of LpxC for the treatment of Gram-negative infections. | Pfizer |
20005097 | 58 | Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. | Pfizer |